You have 9 free searches left this month | for more free features.

Condition

Colon Carcinoma (1)

Glioblastoma (1)

Microsatellite Stable Colorectal Cancer (1)

Microsatellite Unstable Colorectal Cancer (1)

Mismatch Repair Deficient Colorectal Cancer (1)

Mismatch Repair Proficient Colorectal Cancer (1)

Overall Status

Recruiting (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Bristol-Myers Squibb (1)

National Institute of Neurological Disorders and Stroke (NINDS) (1)

The Netherlands Cancer Institute (1)

Collaborator

Bristol-Myers Squibb (1)

Intervention

bms-986016 (3)

nivolumab (3)

ipilimumab (2)

bms-986253 (1)

celecoxib 200mg (1)

cobimetinib (1)

daratumumab (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (1)

NIH (1)

Other (1)

Study Type

Interventional (3)

bms-986016

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Glioblastoma Trial in Atlanta, Bethesda (Nivolumab, BMS-986016)

Recruiting

Glioblastoma

Nivolumab
BMS-986016

Atlanta, Georgia
+1 more

Sep 21, 2022

Colon Carcinoma Trial in Netherlands (Nivolumab, Ipilimumab, Celecoxib 200mg)

Recruiting

Colon Carcinoma

Nivolumab
+4 more

Amsterdam, Netherlands
+5 more

Jan 23, 2023

Microsatellite Unstable Colorectal Cancer, Microsatellite Stable Colorectal Cancer, Mismatch Repair Proficient Colorectal Cancer

Active, not recruiting

Microsatellite Unstable Colorectal Cancer
+3 more

Ipilimumab
+4 more

Gilbert, Arizona
+31 more

Dec 21, 2021